FGF23 and chronic kidney disease: The strength of our study is that we used two mouse models in parallel; CKD mice, and non‐CKD mice with high exogenous FGF23 concentrations, both models with chronically increased circulating FGF23 levels, therefore representing chronic clinical exposure to FGF23 in a CKD setting or not.